Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease

Autoimmunity

Volumn 48, Issue 1, 2015, Pages 13-18

  Liu, Zehuan ^a   Xiao, Wenjuan ^a   Liu, Zelin ^a   Lin, Jianghai ^a   Li, Jingbo ^a   Wu, Kejing ^a   Ma, Yun ^a   Gong, Yingxue ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Association; Case control study; Graves' disease; Single nucleotide polymorphisms; Toll like receptor

Indexed keywords

TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 6; TLR10 PROTEIN, HUMAN; TLR6 PROTEIN, HUMAN; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 10; TOLL-LIKE RECEPTOR 6;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 1 GENE; TOLL LIKE RECEPTOR 10 GENE; TOLL LIKE RECEPTOR 6 GENE; ALLELES; CASE-CONTROL STUDIES; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETICS; HAPLOTYPES; HUMANS; IMMUNOLOGY; LINKAGE DISEQUILIBRIUM; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 10; TOLL-LIKE RECEPTOR 6;

EID: 84919792317     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.939269     Document Type: Article

References (48)

1. Adams, D. D. 1980. Thyroid-stimulating autoantibodies. Vitam. Horm. 38: 119-203.
2. McIver, B., and J. C. Morris. 1998. The pathogenesis of Graves' disease. Endocrinol. Metab. Clin. North. Am. 27: 73-89.
3. Ayadi, H., H. Hadj Kacem, A. Rebai, and N. R. Farid. 2004. The genetics of autoimmune thyroid disease. Trends. Endocrinol. Metab. 15: 234-239.
4. Tomer, Y. 2010. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 20: 715-725.
5. Hasham, A., and Y. Tomer. 2012. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol. Res. 54: 204-213.
6. Bossowski, A., H. Borysewicz-Sanczyk, N. Wawrusiewicz-Kurylonek, et al. 2014. Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases. Autoimmunity [Epub ahead of print]. doi: 10.3109/08916934.2014.910767.
7. Chu, X., C. M. Pan, S. X. Zhao, et al. 2011. A genome-wide association study identifies two new risk loci for Graves' disease. Nat. Genet. 43: 897-901.
8. Ban, Y., T. Tozaki, and M. Taniyama. 2013. The replication of the association of the rs9355610 within 6p27 with Graves' disease. Autoimmunity. 46: 395-398.
9. Morita, M., M. Watanabe, N. Inoue, et al. 2012. Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease. Autoimmunity. 45: 129-136.
10. Yang, Y., X. Su, K. Zhang, and R. Zhou. 2013. The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: an updated meta-analysis. Autoimmunity. 46: 547-558.
11. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
12. Chang, Z. L. 2010. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm. Res. 59: 791-808.
13. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell. 124: 783-801.
14. Chuang, T., and R. J. Ulevitch. 2001. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta. 1518: 157-161.
15. Guan, Y., D. R. Ranoa, S. Jiang, et al. 2010. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J. Immunol. 184: 5094-5103.
16. Veltkamp, M., C. H. van Moorsel, G. T. Rijkers, et al. 2012. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue. Antigens. 79: 25-32.
17. Stevens, V. L., A. W. Hsing, J. T. Talbot, et al. 2008. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int. J. Cancer. 123: 2644-2650.
18. Requena, T., I. Gazquez, A. Moreno, et al. 2013. Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease. Immunogenetic. 65: 345-355.
19. Misch, E. A., A. Verbon, J. M. Prins, et al. 2013. A TLR6 polymorphism is associated with increased risk of Legionnaires' disease. Genes Immun. 14: 420-426.
20. Morgan, A. R., W. J. Lam, D. Y. Han, et al. 2012. Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand population. Hum. Immunol. 73: 416-420.
21. Thompson, C. M., T. D. Holden, G. Rona, et al. 2014. Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study. Ann. Surg. 259: 179-185.
22. Eschler, D. C., A. Hasham, and Y. Tomer. 2011. Cutting edge: the etiology of autoimmune thyroid diseases. Clin. Rev. Aller. Immunol. 41: 190-197.
23. Hargreaves, C. E., M. Grasso, C. S. Hampe, et al. 2013. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease. J. Immunol. 190: 5373-5381.
24. Figura, N., G. Di Cairano, F. Lore, et al. 1999. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J. Physiol. Pharmacol. 50: 817-826.
25. Benvenga, S., F. Guarneri, M. Vaccaro, et al. 2004. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid. 14: 964-966.
26. Jaspan, J. B., H. Luo, B. Ahmed, et al. 1995. Evidence for a retroviral trigger in Graves' disease. Autoimmunity. 20: 135-142.
27. Menconi, F., A. Hasham, and Y. Tomer. 2011. Environmental triggers of thyroiditis: hepatitis C and interferon-alpha. J. Endocrinol. Invest. 34: 78-84.
28. Caturegli, P., H. Kimura, R. Rocchi, and N. R. Rose. 2007. Autoimmune thyroid diseases. Curr. Opin. Rheumatol. 19: 44-48.
29. Harii, N., C. J. Lewis, V. Vasko, et al. 2005. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. Mol. Endocrinol. 19: 1231-1250.
30. Kawashima, A., K. Yamazaki, T. Hara, et al. 2013. Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactions. Thyroid. 23: 477-487.
31. Nicola, J. P., M. L. Velez, A. M. Lucero, et al. 2009. Functional toll-like receptor 4 conferring lipopolysaccharide responsiveness is expressed in thyroid cells. Endocrinology. 150: 500-508.
32. Finke, D., M. L. Eloranta, and L. Ronnblom. 2009. Endogenous type I interferon inducers in autoimmune diseases. Autoimmunity. 42: 349-352.
33. Yan, N., Y. L. Yu, J. Yang, et al. 2012. Association of interleukin-17A and-17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity. 45: 533-539.
34. Molnar, I.2007. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy. Autoimmunity. 40: 31-37.
35. Liao, W.-L., R.-H. Chen, H.-J. Lin, et al. 2010. Toll-like receptor gene polymorphisms are associated with susceptibility to graves' ophthalmopathy in Taiwan males. BMC Med. Genet. 11: 154.
36. Carlson, C., M. Eberle, M. Rieder, et al. 2004. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74: 106-120.
37. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21: 263-265.
38. Stephens, M., N. J. Smith, and P. Donnelly. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978-989.
39. Stephens, M., and P. Scheet. 2005. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76: 449-462.
40. Hamann, L., C. Glaeser, A. Hamprecht, et al. 2006. Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin. Chim. Acta. 364: 303-307.
41. Wang, Y. L., M. S. Tan, J. T. Yu, et al. 2013. Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer's disease in Han Chinese. J. Neuroinflammation. 10: 101-105.
42. Zhang, J., Q. Zhu, F. Meng, et al. 2014. Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population. Gene. 533: 385-388.
43. Perros, P., A. L. Crombie, J. N. Matthews, and P. Kendall-Taylor. 1993. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin. Endocrinol (Oxf). 38: 367-372.
44. Yamada, T., T. Aizawa, Y. Koizumi, et al. 1994. Age-related therapeutic response to antithyroid drug in patients with hyperthy-roid Graves' disease. J. Am. Geriatr. Soc. 42: 513-516.
45. Allahabadia, A., J. Daykin, R. L. Holder, et al. 2000. Age and gender predict the outcome of treatment for Graves' hyperthyroid-ism. J. Clin. Endocrinol. Metab. 85: 1038-1042.
46. Melcescu, E., W. B. Horton, D. Kim, et al. 2014. Graves orbitopathy: update on diagnosis and therapy. South. Med. J. 107: 34-43.
47. Paavonen, T. 1994. Hormonal regulation of immune responses. Ann. Med. 26: 255-258.
48. Da Silva, J. A. 1995. Sex hormones, glucocorticoids and auto-immunity: facts and hypotheses. Ann. Rheum. Dis. 54: 6-16.